Table 1 Summary of clinical features associated with MSL2 PTVs.

From: Novel protein-truncating variants of a chromatin-modifying gene MSL2 in syndromic neurodevelopmental disorders

 

Patient 1

Patient 2

Patient 3

Age (year)

6

11

16

Sex

female

male

female

MSL2 variants

(NM_018133.3):c.796-797delCT, p.(Leu266Valfs*5); De novo

(NM_018133.4):c.1047-1050del, p.Ser349Argfs*23; mother is negative and father not tested

(NM_018133.4):c.67 G > T, p.Gly23*; parents were not tested

Growth

normal

normal

normal

Hypotonia

Yes

Yes

Yes

Face dysmorphism

Yes

Yes

No

Other physical features

Webbed neck

pectus excavatum deformity

joint hypermobility

DD

global developmental delay

global developmental delay

Motor delay

ID

Yes

Yes

No

ASD

Yes

not evaluated

No

Other behavioral disorders

anxiety and self-injurious behavior

self-injurious and aggressive behavior

regression of motor skills

Seizure

No

Yes

No

EEG

not evaluated

abnormal

not evaluated

MRI of brain

unremarkable

abnormal

not evaluated

Family history

negative

negative

similar symptom in mother and maternal grand mother